跳至主要内容
临床试验/NCT00899132
NCT00899132终止不适用

The Role of TAB3 Protein in Tumorigenesis

Case Comprehensive Cancer Center1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2007年2月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
180
试验地点
1
主要终点
Identification of TAB3 transcript/protein as a molecular marker of cancer

研究概览

简要总结

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is evaluating a tumor marker for testicular cancer, skin cancer, small intestine cancer, and pancreatic cancer.

详细描述

OBJECTIVES:

  • To identify TAB3 transcript/protein as a molecular marker of cancer, specifically testicular, skin, small intestine, and pancreatic cancer.
  • To characterize TAB3 and its signaling networks that are involved in tumorigenesis.

OUTLINE: Tumor tissue samples from paraffin-embedded tissue blocks are analyzed for TAB3 transcript and protein expression using in situ hybridization and immunostaining with TAB3 cRNA probe and antibody. Antibodies against the proteins involved in the NFkB signaling pathway (e.g., p65, TAK1, MyD88, and Akt) are used in the immunostaining assays.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Identification of TAB3 transcript/protein as a molecular marker of cancer

时间窗: end of study

Characterization of TAB3 and its signaling networks that are involved in tumorigenesis

时间窗: end of study

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验